Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study (Q33331105)
scientific article
Language:
Current Data About Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study
(P31) (Q13442814)
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

(P50) (Q30512486)
(P1545) 1
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

(Q105453590)
(P1545) 9
(P1932) J M Small

(P304) 106-115
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

(P407) (Q1860)

(P433) 1
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

(P478) 18
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

(P577) Saturday, January 1, 2000
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

(P921) (Q181600)

(Q172341)
(P887)

(Q412415)
(P887)

(Q5625186)
(P887)

(Q423762)
(P887)

(P1433) (Q400292)
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

(P1476) "Phase III randomized study of cisplatin versus paclitaxel versus cisplatin and paclitaxel in patients with suboptimal stage III or IV ovarian cancer: a gynecologic oncology group study" (language: en)
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

(P2093) P S Braly
(P1545) 2
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

M F Brady
(P1545) 3
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

G Sutton
(P1545) 4
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

T H Niemann
(P1545) 5
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

S L Lentz
(P1545) 6
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

R D Alvarez
(P1545) 7
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

P R Kucera
(P1545) 8
(P248)
(P698) 10623700
(P813) Tuesday, July 25, 2017

other details
description scientific article

External Links
(P356) 10.1200/JCO.2000.18.1.106
(P698) 10623700